a. Low hematocrit of RBC unit (extended-storage AP
b. Inappropriate calculation of transfusion requirement
Fig. 43.1. Neonatal syringe set with filter. (Courtesy of Charter
Medical Ltd., Winston-Salem, North Carolina). This system,
when used with sterile connection technology, provides a closed
delivery system that maintains primary unit outdate. Syringe blood
aliquots (PRCBs, plasma) must be administered to the patient
within 24 hours and syringe platelet aliquots within 4 hours.
Chapter 43 ■ Transfusion of Blood and Blood Products 307
e. Hemolysis due to ABO or other RBC incompatibility
(2) Direct antiglobulin test negative initially but
(3) Unexpected increase in bilirubin
(4) Infant has RBC antibody other than ABO.
(5) Hemolysis from extrinsic damage (mechanical)
to RBCs or donor has hemolytic disorder.
(6) Hemolysis from T-activation
Fig. 43.2. Use of a sterile connecting device. A: An adult RBC
unit is shown along with a set of pediatric transfer bags. The transfer
bags can be attached by spiking the unit, causing it to expire in
24 hours; alternatively, the transfer bags can be connected using a
sterile connection device. B, C: The separate tubings are loaded
into the tubing holders of the device. The covers are closed. D: A
welding wafer heated to about 500°F melts through the tubing.
The tubing holders realign and the welding wafer retracts allowing
the tubing ends to fuse together. E: The unit can now be aliquoted
308 Section VIII ■ Transfusions
Whole or Reconstituted Whole Blood
A whole blood (WB) unit contains approximately 450 to
V and VIII, does not contain functional platelets or granulocytes, and concentration of K+
prepared by adding a unit of RBCs to a compatible unit of
FFP and is preferable to the use of stored WB (29,30).
1. Massive transfusion as in acute blood loss, in excess of
25% of total blood volume (TBV) when restoration of
blood volume and oxygen-carrying capacity are needed
3. Cardiopulmonary bypass (CPB)
4. Extracorporeal membrane oxygenation
6. There currently exists no consensus within the United
States on the use of fresh WB, reconstituted WB, or
reconstituted fresh WB (RFWB) for CPB pump priming or postoperative transfusion support in neonates
with congenital heart disease.
a. Recent studies have questioned the use of WB (31)
and have suggested an advantage in clinical outcomes in infants with congenital heart disease
receiving RFWB during CPB surgery (32).
b. Additional prospective studies are warranted to
determine optimal age of reconstituted WB units for
neonates undergoing CPB surgery.
c. Fresh WB (<48 hours old) is not universally available.
1. Not suitable for simple transfusion for anemia
2. Not suitable for correction of coagulation factor deficiencies
3. Hyperkalemia may result from rapid transfusion of
4. Anticoagulant (citrate) effects must be considered for
No comments:
Post a Comment
اكتب تعليق حول الموضوع